Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Escitalopram Treatment Report
What is Escitalopram?

Escitalopram is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). It is used to treat anxiety and major depressive disorder. Off label it is used for mild agitation in patients with dementia.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 10%
None
9 90%

Most commonly reported side effects

Sleepiness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 5 mg/5 mL daily 5 mg daily 10 mg daily 15 mg daily 20 mg daily 30 mg daily 40 mg daily
  2 Number of Patients: 2 4 Number of Patients: 4 5 Number of Patients: 5 38 Number of Patients: 38 1 Number of Patients: 1 23 Number of Patients: 23 3 Number of Patients: 3 4 Number of Patients: 4  

Stop Reasons

Why Patients Stopped Taking Escitalopram (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
5 28% Other: 28%
Expense
4 22% Expense: 22%
Doctor's advice
3 17% Doctor's advice: 17%
Did not seem to work
2 11% Did not seem to work: 11%
Side effects too severe
2 11% Side effects too severe: 11%
Course of treatment ended
2 11% Course of treatment ended: 11%

See all 17 patients who’ve stopped taking Escitalopram

Duration See details about how long patients take this treatment ▼

Currently Taking Escitalopram

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Escitalopram

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
8 80%
Usually
2 20%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
10 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 10%
$25-49
2 20%
< $25
2 20%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 12, 2010.